14 research outputs found

    A Full Pharmacological Analysis of the Three Turkey Ī²-Adrenoceptors and Comparison with the Human Ī²-Adrenoceptors

    Get PDF
    There are three turkey Ī²-adrenoceptors: the original turkey Ī²-adrenoceptor from erythrocytes (tĪ²trunc, for which the X-ray crystal structure has recently been determined), tĪ²3C and tĪ²4C-receptors. This study examined the similarities and differences between these avian receptors and mammalian receptors with regards to binding characteristics and functional high and low affinity agonist conformations.Stable cell lines were constructed with each of the turkey Ī²-adrenoceptors and 3H-CGP12177 whole cell binding, CRE-SPAP production and (3)H-cAMP accumulation assays performed. It was confirmed that the three turkey Ī²-adrenoceptors are distinct from each other in terms of amino acid sequence and binding characteristics. The greatest similarity of any of the turkey Ī²-adrenoceptors to human Ī²-adrenoceptors is between the turkey Ī²3C-receptor and the human Ī²2-adrenoceptor. There are pharmacologically distinct differences between the binding of ligands for the tĪ²trunc and tĪ²4C and the human Ī²-adrenoceptors (e.g. with CGP20712A and ICI118551). The tĪ²trunc and tĪ²4C-adrenoceptors appear to exist in at least two different agonist conformations in a similar manner to that seen at both the human and rat Ī²1-adrenoceptor and human Ī²3-adrenoceptors. The tĪ²3C-receptor, similar to the human Ī²2-adrenoceptor, does not, at least so far, appear to exist in more than one agonist conformation.There are several similarities, but also several important differences, between the recently crystallised turkey Ī²-adrenoceptor and the human Ī²-adrenoceptors. These findings are important for those the field of drug discovery using the recently structural information from crystallised receptors to aid drug design. Furthermore, comparison of the amino-acid sequence for the turkey and human adrenoceptors may therefore shed more light on the residues involved in the existence of the secondary Ī²-adrenoceptor conformation
    corecore